Balance Sheet: Liabilities and Stockholders’ Equity
Quarterly Data

The balance sheet provides creditors, investors, and analysts with information on company resources (assets) and its sources of capital (its equity and liabilities). It normally also provides information about the future earnings capacity of a company assets as well as an indication of cash flows that may come from receivables and inventories.

Liabilities represents obligations of a company arising from past events, the settlement of which is expected to result in an outflow of economic benefits from the entity.

Amgen Inc., consolidated balance sheet: liabilities and stockholders’ equity (quarterly data)

US$ in millions

	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Accounts payable	3,010)	2,406)	1,908)	2,147)	2,267)	1,628)	1,590)	1,358)	1,212)	1,320)	1,572)	1,204)	1,256)	1,403)	1,366)	1,171)	1,277)	1,396)	1,421)	1,161)	1,150)	1,338)
Accrued liabilities	15,022)	17,234)	17,641)	14,621)	13,722)	14,127)	15,359)	14,168)	13,718)	12,061)	12,524)	11,584)	10,545)	10,639)	10,731)	9,383)	8,984)	9,917)	10,141)	8,701)	9,282)	8,649)
Current portion of long-term debt	2,444)	3,368)	3,550)	3,544)	5,528)	3,959)	1,443)	1,428)	2,167)	834)	1,591)	1,543)	817)	844)	87)	4,288)	4,324)	1,556)	91)	91)	91)	1,840)
Current liabilities	20,476)	23,008)	23,099)	20,312)	21,517)	19,714)	18,392)	16,954)	17,097)	14,215)	15,687)	14,331)	12,618)	12,886)	12,184)	14,842)	14,585)	12,869)	11,653)	9,953)	10,523)	11,827)
Long-term debt, excluding current portion	53,760)	54,013)	56,549)	56,854)	57,117)	60,061)	63,170)	59,040)	59,377)	60,761)	37,354)	37,161)	35,705)	36,010)	33,222)	33,291)	28,458)	31,129)	32,895)	34,196)	34,133)	30,008)
Long-term deferred tax liabilities	1,386)	1,510)	1,616)	1,711)	1,780)	1,862)	2,354)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)
Long-term tax liabilities	2,511)	2,419)	2,349)	2,280)	2,205)	3,964)	4,680)	4,579)	4,478)	5,864)	5,757)	5,680)	5,603)	6,652)	6,594)	6,483)	6,428)	7,037)	6,968)	7,560)	7,556)	8,111)
Other noncurrent liabilities	2,336)	2,210)	2,349)	2,199)	2,363)	2,357)	2,326)	2,305)	2,536)	2,532)	2,662)	2,875)	2,949)	2,732)	2,465)	2,160)	2,055)	2,170)	2,023)	1,969)	2,140)	2,238)
Noncurrent liabilities	59,993)	60,152)	62,863)	63,044)	63,465)	68,244)	72,530)	65,924)	66,391)	69,157)	45,773)	45,716)	44,257)	45,394)	42,281)	41,934)	36,941)	40,336)	41,886)	43,725)	43,829)	40,357)
Total liabilities	80,469)	83,160)	85,962)	83,356)	84,982)	87,958)	90,922)	82,878)	83,488)	83,372)	61,460)	60,047)	56,875)	58,280)	54,465)	56,776)	51,526)	53,205)	53,539)	53,678)	54,352)	52,184)
Common stock and additional paid-in capital; $0.0001 par value	33,680)	33,578)	33,533)	33,393)	33,204)	33,082)	33,070)	32,753)	32,601)	32,535)	32,514)	32,371)	31,343)	31,247)	32,096)	31,989)	31,877)	31,806)	31,802)	31,713)	31,610)	31,525)
Accumulated deficit	(25,708)	(27,140)	(27,590)	(25,530)	(27,124)	(27,870)	(26,549)	(24,971)	(25,540)	(26,919)	(28,622)	(28,066)	(28,252)	(29,568)	(24,600)	(22,964)	(22,762)	(21,639)	(21,408)	(19,851)	(20,168)	(21,378)
Accumulated other comprehensive loss	(544)	(231)	(66)	(336)	(155)	(190)	(289)	(126)	(280)	(268)	(231)	(652)	(672)	(763)	(796)	(808)	(868)	(833)	(985)	(903)	(783)	(662)
Stockholders’ equity	7,428)	6,207)	5,877)	7,527)	5,925)	5,022)	6,232)	7,656)	6,781)	5,348)	3,661)	3,653)	2,419)	916)	6,700)	8,217)	8,247)	9,334)	9,409)	10,959)	10,659)	9,485)
Total liabilities and stockholders’ equity	87,897)	89,367)	91,839)	90,883)	90,907)	92,980)	97,154)	90,534)	90,269)	88,720)	65,121)	63,700)	59,294)	59,196)	61,165)	64,993)	59,773)	62,539)	62,948)	64,637)	65,011)	61,669)

Accounts Payable: Accounts payable demonstrated a fluctuating pattern across the periods. Starting at 1,338 million USD in March 2020, it saw decreases and increases, notably rising to a peak of 3,010 million USD in June 2025, indicating increased short-term obligations over time.
Accrued Liabilities: Accrued liabilities generally increased throughout the timeline. Beginning at 8,649 million USD in March 2020, it peaked at 17,641 million USD in June 2025. This trend reflects growing expenses incurred but not yet paid.
Current Portion of Long-Term Debt: This line item showed significant volatility, with very low values (around 91 million USD) in mid-2020 and end of 2020, then spiking at various points, such as 5,528 million USD in June 2024. This suggests refinancing activities or varying repayment schedules.
Current Liabilities: Current liabilities fluctuated between approximately 9,953 million USD and 23,099 million USD. A general increasing trend is observable, with the highest values recorded in mid-2025, pointing to greater short-term debt obligations.
Long-Term Debt, Excluding Current Portion: Long-term debt values showed initial stability around 30,000 to 34,000 million USD from 2020 to 2021, followed by a significant increase to over 60,000 million USD during 2023 and 2024. This doubling signals increased leverage or debt financing in recent periods.
Long-Term Deferred Tax Liabilities: Data was only available from March 2024 onwards and showed a gradual decline from 2,354 million USD to 1,386 million USD by June 2025, reflecting a possible reduction in future tax obligations.
Long-Term Tax Liabilities: Long-term tax liabilities decreased overall from 8,111 million USD in March 2020 to 2,511 million USD by June 2025, showing a steady downward trend that could indicate effective tax management or reduced tax exposures.
Other Noncurrent Liabilities: Other noncurrent liabilities remained relatively stable, fluctuating narrowly between about 2,100 and 2,700 million USD, with no clear trend over the periods.
Noncurrent Liabilities: Noncurrent liabilities showed growth from about 40,357 million USD in March 2020 to a peak of 72,530 million USD by December 2023. Thereafter, it slightly declined, signaling increased long-term financial commitments but some stabilization toward 2025.
Total Liabilities: Total liabilities rose from 52,184 million USD in March 2020 to a peak of 90,922 million USD in December 2023, before decreasing modestly to about 80,469 million USD by June 2025. This overall increase reflects expanded financial leverage.
Common Stock and Additional Paid-in Capital: This equity component steadily increased from 31,525 million USD in March 2020 to 33,680 million USD by June 2025, indicating consistent capital injections or retained earnings allocated to equity.
Accumulated Deficit: The accumulated deficit deepened initially from -21,378 million USD in March 2020, reaching a trough of -29,568 million USD in March 2022. Subsequently, it improved toward -25,708 million USD by June 2025, indicating some recovery in retained earnings or profitability.
Accumulated Other Comprehensive Loss: Accumulated other comprehensive loss mostly fluctuated with minor variations, ranging between -903 million USD and -66 million USD, reflecting periodic changes in unrealized gains or losses on investments or other comprehensive income items.
Stockholders’ Equity: Stockholders’ equity showed considerable volatility, initially decreasing from 9,485 million USD in March 2020 to 916 million USD in March 2022, before rebounding to 7,428 million USD by December 2024. However, slight declines occurred after late 2024. This pattern suggests periods of both financial strain and recovery.
Total Liabilities and Stockholders’ Equity: The total capitalization rose from 61,669 million USD in March 2020 to a high near 97,154 million USD in December 2023, then gradually declined to about 87,897 million USD by June 2025. This reflects the overall scale of the balance sheet expanding, followed by some contraction.

Download chart

Amgen Inc. (NASDAQ:AMGN)

Balance Sheet: Liabilities and Stockholders’ Equity Quarterly Data

Balance Sheet: Liabilities and Stockholders’ Equity
Quarterly Data